Mesoblast (ASX:MSB) Share Price and News - StockTrack

Market Cap (19-Sep) $2,805,431,552 (333rd)	Close (30-Jun) $1.14 0 (0%)	Volume (30-Jun) 2,606,681	Shortsold (26-May) 113,385,425 (8.76%) (25th)
52w High $3.31	52w Low $1.53	P/E 454.55	EPS -0.1

	Subject
	MSB MSB Ann: Appendix 3G, Appendix 3H and Appendix 3Y
	1 (current) 2 3
	MSB MSB Ann: Amended Constitution
	MSB MSB Ann: Results of Meeting
	MSB MSB Article: NZ dollar jumps after RBNZ lifts rates by record 0.75pc
	MSB MSB Article: RBNZ lifts rates 0.75pc to 4.25pc in record high increase
	MSB MSB Ann: Chairman's Address to Shareholders
	MSB MSB Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
	MSB MSB Ann: MSB Q1 Financial Results and Operational Highlights
	MSB MSB Ann: CEO First Quarter Results and 2022 AGM Presentation
	MSB MSB Ann: First Quarter Financial Results on Form 6-K
	MSB MSB Ann: Mesoblast First Quarter Financial Results Webcast
	MSB MSB Ann: Removal of Amendment to Constitution About Virtual Meetings
	MSB MSB Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	MSB MSB Ann: Notice of Annual General Meeting and Proxy Form
	MSB MSB Ann: Annual Report to Shareholders
	MSB MSB Ann: Appendix 4G and Corporate Governance Statement
	MSB MSB Ann: Notification of cessation of securities - MSB
	MSB MSB Ann: Submits New Information to FDA IND File for SR-aGVHD
	MSB MSB Ann: Change of Director's Interest Notice
	MSB MSB Ann: Change of Director's Interest Notice
	MSB MSB Ann: MSB Annual Financial Results and Operational Highlights
	MSB MSB Ann: Annual Financial Results Presentation
	MSB MSB Ann: Preliminary Final Report
	MSB MSB Ann: Mesoblast 2022 Full Year Financial Results Webcast
	MSB MSB Ann: Director Appointment
	MSB MSB Ann: Initial Director's Interest Notice
	MSB MSB Ann: Final Director's Interest Notice
	MSB MSB Ann: Ceasing to be a substantial holder - Tiga Trading Pty Ltd
	MSB MSB Ann: Ceasing to be a substantial holder from TEK
	MSB MSB Ann: Ceasing to be a substantial holder from TOP
	MSB MSB Ann: Change in substantial holding
	MSB MSB Ann: Cleansing Notice
	MSB MSB Ann: Appendix 2A
	MSB MSB Ann: Appendix 3B
	MSB MSB Ann: US$45 Million Private Placement to Major Shareholders
	MSB MSB Ann: Reinstatement to Quotation
	MSB MSB Ann: Voluntary Suspension
	MSB MSB Ann: Trading Halt
	MSB MSB Ann: Pause in Trading
	MSB MSB Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	MSB MSB Ann: Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE
	MSB MSB Ann: Appendix 3H and Appendix 3Y
	MSB MSB Ann: Rexlemestrocel-L to be Highlighted on Heart Failure Panel
	MSB MSB Article: Dogs rule in unsteady start to new financial year
	MSB MSB Ann: Mesoblast CLBP Event with Key Opinion Leaders
	MSB MSB Ann: Chronic Low Back Pain KOL Event Presentation
	MSB MSB Ann: Litigation Update
	MSB MSB Article: Mesoblast accused of misleading investors
	MSB MSB Ann: Mesoblast to Host KOL Event on Chronic Low Back Pain
	MSB MSB Ann: Third Quarter Results Presentation

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
18-Sep	$2.35	3,962,829	+0.14 (6.33%)
12-Sep	$2.21	3,620,688	-0.11 (4.74%)
11-Sep	$2.32	6,767,523	+0.20 (9.43%)
05-Sep	$2.12	5,286,662	+0.13 (6.53%)
04-Sep	$1.99	6,352,553	+0.05 (2.58%)
03-Sep	$1.94	4,517,976	-0.24 (11.01%)
29-Aug	$2.18	12,569,254	-0.24 (9.92%)
28-Aug	$2.42	2,465,632	+0.04 (1.68%)
22-Aug	$2.38	1,761,217	+0.01 (0.42%)
21-Aug	$2.37	2,206,174	-0.14 (5.58%)
15-Aug	$2.51	4,062,683	+0.08 (3.29%)
14-Aug	$2.43	3,241,108	+0.07 (2.97%)
07-Aug	$2.36	3,518,224	-0.02 (0.84%)
31-Jul	$2.38	3,711,697	-0.07 (2.86%)
30-Jul	$2.45	3,975,941	-0.04 (1.61%)
8 up, 7 down, and 0 flat days

High $1.17	Low $1.13	Trades 1,304	Turnover $2,983,889	Volume 2,606,681
30 June 2023 at 4:10pm

High $1.17	Low $1.13	Trades 1,304	Turnover $2,983,889	Volume 2,606,681
30 June 2023 at 4:10pm

Mesoblast Health Care
Biopharmaceuticals Cancer Medicine Oncology

$1.14 -0.01 (-0.44%)

$1.14 -0.01 (-0.44%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Mesoblast Health Care Biopharmaceuticals Cancer Medicine Oncology

$1.14 -0.01 (-0.44%)

$1.14 -0.01 (-0.44%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Mesoblast Health Care
Biopharmaceuticals Cancer Medicine Oncology